Paper208459
5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses.
Renis HE. Antimicrob Agents Chemother, 1978. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. 5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses. Papers, record 208459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/208459
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Simplexvirus | Major topic |
| Thymidine | Major topic |
| Animals | |
| Humans | |
| Rabbits | |
| Time Factors | |
| Vaccinia virus |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14219080 | INHIBITION BY METABOLIC ANALOGUES OF PLAQUE FORMATION BY HERPES ZOSTER AND HERPES SIMPLEX VIRUSES. | J Immunol | 1964 | https://conductscience.org/library/papers/14219080 | PubMed |
| 2 | 14454445 | Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine. | Proc Soc Exp Biol Med | 1962 | https://conductscience.org/library/papers/14454445 | PubMed |
| 3 | 14454436 | Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis. | Arch Ophthalmol | 1962 | https://conductscience.org/library/papers/14454436 | PubMed |
| 4 | 184048 | Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation. | Infect Immun | 1976 | https://conductscience.org/library/papers/184048 | PubMed |
| 5 | 212988 | A rational approach to the development of antiviral chemotherapy: alternative substrates of herpes simplex virus Type 1 (HSV-1) and Type 2 (HSV-2) thymidine kinase (TK). | Ann N Y Acad Sci | 1977 | https://conductscience.org/library/papers/212988 | PubMed |
| 6 | 212984 | The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness? | Ann N Y Acad Sci | 1977 | https://conductscience.org/library/papers/212984 | PubMed |
| 7 | 5466741 | Comparison of cytotoxicity and antiviral activity of 1-beta-D-arabino-furanosyl-5-iodocytosine with related compounds. | Cancer Res | 1970 | https://conductscience.org/library/papers/5466741 | PubMed |
| 8 | 856033 | Efficacy of 5,6-dihydro-5-azathymidine against cutaneous herpes simplex virus in hairless mice. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/856033 | PubMed |
| 9 | 856023 | Chemotherapy of genital herpes simplex virus type 2 infections of female hamsters. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/856023 | PubMed |
| 10 | 167186 | Selective inhibition of herpes simplex virus by 5-amino-2,5-dideoxy-5-iodouridine. | J Virol | 1975 | https://conductscience.org/library/papers/167186 | PubMed |
| 11 | 167520 | Inhibition of herpes simplex virus replication by araT. | Virology | 1975 | https://conductscience.org/library/papers/167520 | PubMed |
| 12 | 938547 | Nucleoside analogs with antiviral activity. | Biochem Pharmacol | 1976 | https://conductscience.org/library/papers/938547 | PubMed |
| 13 | 197886 | Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/197886 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 426515 | Activities of 5,6-dihydro-5-azathymidine against herpes simplex virus infections in mice. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/426515 | PubMed |
| 230783 | Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/230783 | PubMed |
| 224809 | Effect of 5-iodo-5'-amino-2',5'-dideoxyuridine on varicella-zoster virus in vitro. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/224809 | PubMed |
| 223163 | (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/223163 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/208459
GET https://conductscience.org/api/papers/v1/208459/authors